targeted radiotherapy bone marrow using radiolabeled monoclonal antibodies therapeutic approach considerable potential treatment acute leukemia addition substitute total body irradiation data currently available NUMBER patients suggest radioimmunotherapy rit acute leukemia feasible safe using variety antibodies anticd45 radionuclides 131i 90y 188re appears reduce risk relapse acute myelogenous leukemia aml patients transplanted early course disease NUMBER blasts furthermore shown potential safely intensify conditioning regimens nonrelapse mortality NUMBER compared relapse rate NUMBER NUMBER years significant improvements results refractory patients probably depend successful development rit use cocktail antibodies labeled dose escalation study anticd33 refractory aml partial remission achieved patients randomized trials evaluate therapeutic efficacy rit context stem cell transplantation initiated results keenly anticipated references NUMBER beta emitters anti cd33 anti cd66 high risk NUMBER NUMBER reduced intensity alpha emitters alpha beta emitters 213bi labeled NUMBER NUMBER